Holen Sie sich die Stockscreener-App
63.50
0.11%
0.07
Handel nachbörslich:
63.48
-0.02
-0.03%
Schlusskurs vom Vortag:
$63.43
Offen:
$63.46
24-Stunden-Volumen:
1.61M
Relative Volume:
0.68
Marktkapitalisierung:
$7.92B
Einnahmen:
$692.26M
Nettoeinkommen (Verlust:
$-512.41M
KGV:
-14.98
EPS:
-4.24
Netto-Cashflow:
$-274.36M
1W Leistung:
+8.55%
1M Leistung:
+42.95%
6M Leistung:
+50.80%
1J Leistung:
+142.83%
1-Tages-Spanne:
$63.28
$64.70
1-Wochen-Bereich:
$57.94
$64.70
52-Wochen-Spanne:
$20.14
$64.70
Guardant Health Inc Stock (GH) Company Profile
Firmenname
Guardant Health Inc
Sektor
Branche
Telefon
855-698-8887
Adresse
3100 HANOVER STREET, PALO ALTO
Vergleichen Sie GH mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
GH
Guardant Health Inc
|
63.50 | 7.91B | 692.26M | -512.41M | -274.36M | -4.24 |
|
TMO
Thermo Fisher Scientific Inc
|
488.12 | 184.46B | 43.21B | 6.58B | 6.17B | 17.29 |
|
DHR
Danaher Corp
|
205.00 | 147.69B | 24.01B | 3.41B | 4.86B | 4.70 |
|
IDXX
Idexx Laboratories Inc
|
640.86 | 51.34B | 4.04B | 985.66M | 774.34M | 12.01 |
|
A
Agilent Technologies Inc
|
118.69 | 33.60B | 6.63B | 1.17B | 1.19B | 4.05 |
|
IQV
Iqvia Holdings Inc
|
188.80 | 31.92B | 15.70B | 1.24B | 2.01B | 6.91 |
Guardant Health Inc Stock (GH) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-04-10 | Eingeleitet | Mizuho | Outperform |
| 2025-01-23 | Eingeleitet | Barclays | Overweight |
| 2024-06-28 | Hochstufung | Guggenheim | Neutral → Buy |
| 2024-06-03 | Fortgesetzt | Jefferies | Buy |
| 2024-04-24 | Fortgesetzt | Craig Hallum | Buy |
| 2023-12-14 | Eingeleitet | Guggenheim | Neutral |
| 2023-12-13 | Eingeleitet | Wolfe Research | Peer Perform |
| 2023-11-13 | Hochstufung | Raymond James | Mkt Perform → Outperform |
| 2023-09-28 | Eingeleitet | Bernstein | Outperform |
| 2023-09-27 | Hochstufung | Piper Sandler | Neutral → Overweight |
| 2023-07-05 | Fortgesetzt | JP Morgan | Overweight |
| 2023-05-26 | Hochstufung | Citigroup | Neutral → Buy |
| 2023-05-05 | Eingeleitet | UBS | Buy |
| 2023-03-09 | Herabstufung | Citigroup | Buy → Neutral |
| 2023-01-05 | Eingeleitet | Scotiabank | Sector Outperform |
| 2022-11-01 | Herabstufung | Piper Sandler | Overweight → Neutral |
| 2022-10-19 | Eingeleitet | Craig Hallum | Buy |
| 2022-10-06 | Eingeleitet | Stephens | Overweight |
| 2022-08-25 | Eingeleitet | Credit Suisse | Outperform |
| 2022-06-03 | Eingeleitet | Piper Sandler | Overweight |
| 2022-04-28 | Fortgesetzt | BTIG Research | Buy |
| 2022-02-24 | Bestätigt | Canaccord Genuity | Buy |
| 2022-02-24 | Bestätigt | Citigroup | Buy |
| 2022-02-24 | Bestätigt | Cowen | Outperform |
| 2022-02-24 | Bestätigt | Morgan Stanley | Overweight |
| 2022-02-24 | Bestätigt | SVB Leerink | Outperform |
| 2022-02-24 | Bestätigt | Stifel | Buy |
| 2022-02-24 | Bestätigt | Wells Fargo | Overweight |
| 2021-10-15 | Fortgesetzt | Cowen | Outperform |
| 2021-06-15 | Eingeleitet | Raymond James | Mkt Perform |
| 2021-06-03 | Eingeleitet | Goldman | Buy |
| 2021-05-25 | Eingeleitet | Wells Fargo | Overweight |
| 2021-01-11 | Eingeleitet | Stifel | Buy |
| 2020-09-09 | Eingeleitet | Morgan Stanley | Overweight |
| 2020-06-12 | Eingeleitet | BTIG Research | Buy |
| 2020-02-21 | Eingeleitet | Guggenheim | Buy |
| 2020-01-07 | Eingeleitet | Citigroup | Buy |
| 2019-08-07 | Bestätigt | Canaccord Genuity | Buy |
| 2019-04-16 | Eingeleitet | Canaccord Genuity | Buy |
| 2019-04-10 | Hochstufung | BofA/Merrill | Neutral → Buy |
| 2019-02-28 | Bestätigt | BofA/Merrill | Neutral |
| 2018-10-29 | Eingeleitet | BofA/Merrill | Neutral |
| 2018-10-29 | Eingeleitet | JP Morgan | Overweight |
| 2018-10-29 | Eingeleitet | William Blair | Outperform |
Alle ansehen
Guardant Health Inc Aktie (GH) Neueste Nachrichten
Will Guardant Health Inc. stock recover after recent drop2025 Analyst Calls & Verified Entry Point Detection - Newser
Will Guardant Health Inc. bounce back from current supportJuly 2025 Levels & Low Drawdown Momentum Ideas - Newser
Live market analysis of Guardant Health Inc.Fed Meeting & Real-Time Sentiment Analysis - Newser
Guardant Health Inc. stock prediction for this week2025 Big Picture & Breakout Confirmation Trade Signals - Newser
Detecting price anomalies in Guardant Health Inc. with AIIndex Update & Community Shared Stock Ideas - Newser
Signal strength of Guardant Health Inc. stock in tech scannersWeekly Profit Recap & Fast Entry Momentum Trade Alerts - Newser
Technical signs of recovery in Guardant Health Inc.2025 AllTime Highs & High Accuracy Swing Trade Signals - Newser
Guardant Health Inc. At Critical Juncture — Bounce or BreakdownWeekly Profit Analysis & Weekly Return Optimization Alerts - beatles.ru
Advanced analytics toolkit walkthrough for Guardant Health Inc.Weekly Trade Summary & Detailed Earnings Play Strategies - Newser
When is the best time to exit Guardant Health Inc.July 2025 Sentiment & Expert Verified Movement Alerts - Newser
Can Guardant Health Inc. hit a new high this monthQuarterly Growth Report & High Yield Stock Recommendations - Newser
How to read the order book for Guardant Health Inc.2025 Pullback Review & Weekly Market Pulse Alerts - Newser
Guardant Health's Strategic Visibility in Key Healthcare Conferences and Its Implications for Investor Confidence - AInvest
Guardant Health to Participate in the Morgan Stanley 23rd Annual Global Healthcare Conference - Yahoo Finance
Can Guardant Health Inc. rally from current levelsJuly 2025 Macro Moves & Reliable Price Breakout Signals - Newser
Will Guardant Health Inc. stock split in the near futureWeekly Gains Summary & Step-by-Step Swing Trade Plans - Newser
Is it too late to sell Guardant Health Inc.Market Sentiment Summary & Daily Chart Pattern Signal Reports - Newser
Guardant Drops Cancer Test Trade Secrets Suit Against Natera - Bloomberg Law News
What to do if you’re stuck in Guardant Health Inc.2025 Historical Comparison & Momentum Based Trading Signals - Newser
Analyzing recovery setups for Guardant Health Inc. investorsTrade Volume Summary & Consistent Profit Alerts - Newser
Will Guardant Health Inc. continue its uptrendForecast Cut & Capital Efficient Trade Techniques - Newser
Is Guardant Health Inc. Stock a Smart Buy in 2025 Investment Analysis InsideJuly 2025 Patterns & Fast Moving Trade Plans - Newser
Volume spikes in Guardant Health Inc. stock – what they mean2025 Stock Rankings & Precise Swing Trade Entry Alerts - Newser
Guardant Health Enrolls First Patient in NCI Vanguard Study for Multi-Cancer Detection Test - MSN
Quant Strategy Flags Guardant Health Inc. for EntryJuly 2025 Earnings & Real-Time Buy Zone Alerts - beatles.ru
Guardant Health’s Surprising Surge: Analysis Unpacked - StocksToTrade
Guardant Health stock hits 52-week high at 60.69 USD - Investing.com
Guardant Health Director Tariq Musa Sells 116 Shares at $59.02 on 2025-08-19 - AInvest
Exas, Guardant, Gilead among gainers as Supreme Court ensures free preventive care - MSN
Guardant Health raises 2025 revenue outlook to $915M–$925M amid strong Shield adoption and oncology momentum - MSN
Will Guardant Health Inc. price bounce be sustainableJuly 2025 Catalysts & AI Forecast for Swing Trade Picks - Newser
Is Guardant Health Inc. impacted by rising ratesCEO Change & Real-Time Stock Movement Alerts - thegnnews.com
Can machine learning forecast Guardant Health Inc. recovery2025 Biggest Moves & AI Powered Market Entry Strategies - Newser
Guardant Health Awards Stock Options and RSUs to New Employees Under Nasdaq Listing Rule 5635(c)(4) - AInvest
Guardant Health Inc. Stock Approaches Key Moving Average2025 Bull vs Bear & Long Hold Capital Preservation Tips - metal.it
Will Guardant Health Inc. rebound enough to break evenJuly 2025 Decliners & Precise Entry and Exit Recommendations - Newser
Guardant Health Inc. stock outlook for YEARMarket Weekly Review & Fast Entry High Yield Stock Tips - Newser
Can Guardant Health Inc. be recession proof2025 Stock Rankings & Verified Short-Term Trading Plans - thegnnews.com
Guardant Health Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - 01net
What’s the analyst consensus on Guardant Health Inc.July 2025 Review & Weekly Setup with ROI Potential - kangso.co.kr
Finanzdaten der Guardant Health Inc-Aktie (GH)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.51%
0.31%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):